Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Hospital in Greenland chooses Sectra’s radiology solution—enhanced cross-country collaboration for improved patient care

Linköping, Sweden – September 23, 2024 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will provide its enterprise imaging solution to Dronning Ingrids hospital (DIH) in Greenland. The solution will enhance DIH’s ongoing collaboration with hospitals in Denmark, addressing resource and subspecialty challenges, and ultimately improving patient care in the region.“The partnerships we have with hospitals in Denmark are highly important to us as we, being sparsely populated, struggle to recruit staff and cover medical specialties locally.

Atlas Copco Group appoints Koen Lauwers President of the Vacuum Technique business area

Nacka, Sweden, September 23, 2024: Atlas Copco Group has appointed Koen Lauwers President of the Vacuum Technique business area and member of Group Management, effective January 1, 2025. Koen Lauwers is currently President for the Semiconductor division within the same business area.“Koen is a passionate and respected leader, and he has a broad experience”, said Vagner Rego, President & CEO of Atlas Copco Group. “Through the years he has delivered strong business results and created high value solutions for our customers. I am very pleased that he has agreed to take on this role.” Koen

NYAB signs multi-year framework agreements for energy projects

NYAB Sverige has secured framework agreements for local network projects in Northern Norrland and the Malmfälten region. These agreements, spanning three years with an option for extension for an additional four years, guarantee a project volume of SEK 195 million over the initial contract period.The client is Vattenfall Eldistribution, and the framework agreements continue until the end of 2027. The guaranteed project volume amounts to SEK 40 million per year for the Northern Norrland area and SEK 25 million per year for the Malmfälten area. Projects will be executed as either turnkey

Fasenra recommended for EU approval in EGPA

23 September 2024 Fasenrarecommended for approval in the EU by CHMP for the treatment ofeosinophilic granulomatosis with polyangiitisNew indication supported by the MANDARA trial which showed nearly 60% of patientsachieved remission and 41% of patients fully stopped taking oral corticosteroids  AstraZeneca's Fasenra (benralizumab) has been recommended for approval in the European Union (EU) as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA). EGPA is a rare, immune-mediated vasculitis that can result in

NYAB appoints Mårten Beijar as HR Director and member of the Executive Management Team

NYAB has appointed Mårten Beijar as HR Director of the Group and new member of the Executive Management Team. He will be responsible for strategic management and development of NYAB’s HR activities and will participate in the development of NYAB’s sustainability-related processes. He will start in his position on 7 October 2024. Beijar has extensive international experience in HR leadership. Before joining NYAB, he worked at Fibox Group since 2021, most recently as Executive Vice President, Head of People, Culture and ESG. Previously, he has been HR Director at, among others, Rexel Group

Kemira expands ASA sizing agents capacity in Nanjing, China to respond to increased market demand

Kemira Oyj, Press release, September 23, 2024 at 9.00 EESTKemira expands ASA sizing agents capacity in Nanjing, China to respond to increased market demand   Kemira, the leading ASA (alkenyl succinic anhydride) producer and supplier in Asia-Pacific region has completed a multimillion euro investment to expand the production capacity of ASA sizing agents at its Nanjing site in Jiangsu province in China. The scope of the investment includes a full third production line and additional storage and tank capacity to further improve customer deliveries and supply reliability.   ASA

Final OS results reported for TROPION-Breast01

23 September 2024 Datopotamab deruxtecan final overall survival results reported inpatients with metastatic HR-positive, HER2-low or negative breast cancer inTROPION-Breast01 Phase III trial  Survival results for AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan in TROPION-Breast01 did not achieve statistical significance versus chemotherapy Trial previously met the dual primaryendpoint of progression-free survival High-level results from the TROPION-Breast01 Phase III trial of datopotamab deruxtecan (Dato-DXd) compared to investigator's choice of chemotherapy,

Chief Financial Officer Aku Väliaho leaves NYAB

Aku Väliaho, CFO, has decided to leave NYAB to assume a position outside the Group. Väliaho has been a member of NYAB’s Executive Management Team since January 2022, and he will continue in his role until the end of January 2025. NYAB has started a process to recruit a new CFO for the Company. “I am grateful towards Aku for his significant contribution to NYAB. He has had a vital role in building today’s NYAB by managing our milestone processes such as the reverse acquisition and merger of NYAB and Skarta, transferring our financial reporting to IFRS, successful re-domiciliation to

Fortum to sell its stakes in the biobased solutions businesses in India

FORTUM CORPORATION INVESTOR NEWS 23 SEPTEMBER 2024 AT 9:00 EEST Fortum has signed an agreement to sell its 37.4% ownership in Chempolis Oy, including Fortum’s all biobased solutions businesses, and the shares in the holding company owning 40.3% in Assam Bio Ethanol Pvt Ltd in India to the Indian leading energy transition solutions provider AM Green Technology & Solutions B.V. The transaction will not have any material financial impact on Fortum Group’s result. The transactions are subject to certain closing conditions. The divestment of the biobased solutions businesses is part of

Seventy Agency, a Company Within Lyvia Group, Creates Visuals Concepts for Global Samsung Product Launches

September 23, 2024 - Stockholm, Sweden: Seventy Agency is expanding its global reach through a strategic collaboration with the tech giant Samsung. In the spring of 2024, the agency entered a key partnership with Samsung’s headquarters in Suwon, South Korea, marking a significant milestone in their international efforts.The first results of this collaboration have now been unveiled, with Seventy Agency playing a crucial role in crafting the creative and visual concepts for two major Samsung product launches: the Galaxy Book4 Edge and the Galaxy Ring. These visuals form the core of Samsung’s

Interim Results

23 September 2024     Quantum Blockchain Technologies plc ("QBT", “the Group” or "the Company")     INTERIM RESULTS   Quantum Blockchain Technologies (AIM: QBT), the AIM-listed investment company focusing on a R&D and investment programme within blockchain technology, is pleased to announce its Interim Results for the six months ended 30 June 2024.     For further information please contact:   Quantum Blockchain Technologies Plc Francesco Gardin, CEO and Executive Chairman  +39 335 296573   SP Angel Corporate Finance (Nominated Adviser &

Skanska selected for reservoir construction project in Yonkers, NY, USA, for USD 630M, about SEK 6.6 billion

Skanska has, in a joint venture with ECCO III Enterprises, Inc., signed a contract with the New York City Department of Environmental Protection (NYCDEP) for the Hillview Reservoir Chemical Addition Facilities Construction project in Yonkers, New York, USA. The project is mandated by the Hillview Reservoir Consent Decree and Judgment. The contract is worth USD 848M. Skanska will include its 75 percent share of the contract worth USD 630M, about SEK 6.6 billion, in the US order bookings for the third quarter of 2024.The project scope includes upgrades to the existing North Entrance and the

Sweco to design new kind of mycoprotein plant in Finland

Finnish biotech start-up company Enifer has awarded Sweco a new contract to establish a new plant for the industrial production of mycoprotein. Production starts in 2026, and the plant will be the world's first to utilise side streams from food production on a commercial scale in an industrial symbiosis. Sweco will deliver services for project management, plant design, building permits, procurement and construction management in a project valued at EUR 4.2 million.(Press photo showing mycoprotein, for free use, please credit photographer: Enifer/Iiro Muttilainen)Mycoprotein is a high-

Read original

Aker ASA: Mandatory Notification of Trade

Reference is made to the stock exchange notice by Aker BP ASA ("Aker BP") today regarding Aker BP's annual share purchase programme.Sofie Valdersnes, employee elected board member in Aker ASA and employee in Aker BP, has purchased 546 shares in Aker BP and Håkon Enerstvedt, a person closely associated to Sofie Valdersnes and employee in Aker BP, has purchased 546 shares. The shares in Aker BP are purchased at a discounted price of NOK 182.87 per share, which represents a 20 percent discount to the reference market price, and the shares are subject to a three-year lock-up period.

Employees buy shares in Aker BP

Aker BP has received subscriptions from employees for more than 1.2 million shares at a discounted price of NOK 182.87 per share through the company’s annual share purchase programme. The subscription price represents a 20 percent discount to the reference market price, and the shares are subject to a three-year lock-up period. Approximately 62 percent of the company's employees subscribed in the program, including the following primary insiders: Primary Position  Shares purchased  New holdinginsiderTalar Arif SVP Ula

Management changes at Handelsbanken

Head of Communications, Pernilla Eldestrand, has been appointed to be included in the Bank’s Executive Team as of 1 October. Catharina Belfrage Sahlstrand, currently Head of Handelsbanken Sustainability and Communications, will remain as part of the Executive Team in the role of Head of Handelsbanken Sustainability. For further information, please contact:Michael Green, President and Chief Executive Officer, +46 8 22 92 20Mats Olsson, Press Officer, +46 70 688 07 99 For more information about Handelsbanken, see: www.handelsbanken.com/

NKT completes repair work on Gemini Wind Park connection

Gemini Wind Park, one of the largest offshore wind parks in the Netherlands, is once again fully operational after a failure in one of the export cables between the wind park and the shore. A group of cable and energy specialists, including a repair team from NKT, helped Gemini Wind Park with a fast repair during the summer. The NKT team was responsible for the jointing of the replacement cable between the windfarm and the coast.Press Release23 September 2024 Around 900,000 households are powered by sustainable energy from the Gemini Wind Park. This summer, the wind farm experienced a

Crunchfish carries out a rights issue of units of approximately SEK 57 million

Crunchfish AB (“Crunchfish” or the “Company”), listed on Nasdaq First North Growth Market (“Nasdaq First North”), has today, September 20, 2024, subject to a subsequent approval by the Extraordinary General Meeting on October 24, 2024 (the “EGM”), resolved to carry out a new issue of shares and warrants (“Units”) with preferential rights for existing shareholders of approximately SEK 57 million before issue costs (the “Rights Issue”). The Rights Issue is covered by subscription commitments and guarantee commitments up to approximately 45 percent from larger shareholders and external investors.

FluMist approved for self-administration in US

20 September 2024 FluMist approved for self-administration in the US Only influenza vaccine approved for self- or caregiver-administration at home, expanding options for influenza protection FluMist has been approved in the US as the only self-administered influenza vaccine. FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age.[1] The approval by the US Food and Drug Administration (FDA) was based on a comprehensive submission, which included results from a

There are no items matching the current filter
There are no more items matching the current filter
Back to top